Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 47, Issue 3

Issues

Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease

Maria Mesquita / Anne Demulder / Nasroolla Damry / Christian Mélot / Eric Wittersheim / Dominique Willems / Max Dratwa / Pierre Bergmann
  • 8Department of Clinical Biology, CHU Brugmann, Brussels, Belgium and Laboratory of Experimental Medicine and Department of Nuclear Medicine, CHU Brugmann, Free University of Brussels, Brussels, Belgium
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2009-02-10 | DOI: https://doi.org/10.1515/CCLM.2009.075

Abstract

Background: Cardiovascular disease is the major cause of morbidity and mortality in chronic kidney disease (CKD) and early biomarkers are required which can predict disease and death in such patients. The aim of our study was to investigate if osteoprotegerin (OPG) could be a predictor of coronary artery calcification (CAC) and mortality in CKD.

Methods: A total of 77 outpatients (32 with pre-dialysis CKD and 45 undergoing hemodialysis) were followed-up during 2 years. Measurements of CAC were performed using Siemens Multidetector CT software and calcium scores were measured according to the Agatston method.

Results: OPG was an independent predictor of the Agatston score for CAC and correlated with the degree of CAC in pre-dialysis patients. A two-sample t-test characterized survivors as having a better glomerular filtration rate, lower Agatston scores, and lower serum levels of OPG. Kaplan-Meier survival curves separated survivors from non-survivors at plasma OPG cut-off levels of <3.1 ng/mL. A multivariable logistic regression analysis showed that OPG was an independent predictor of mortality from all causes in CKD patients.

Conclusions: OPG predicted mortality in CKD patients and could be a valuable biomarker in early detection of CAC in these patients.

Clin Chem Lab Med 2009;47:339–46.

Keywords: arteriosclerosis; cardiovascular disease; chronic kidney disease; hemodialysis; osteoprotegerin (OPG); vascular calcification

About the article

Corresponding author: Maria Mesquita, Department of Nephrology and Dialysis, CHU Brugmann, Place A Van Gehuchten 4, 1020 Bruxelles, Belgium


Received: 2008-09-18

Accepted: 2008-12-18

Published Online: 2009-02-10

Published in Print: 2009-03-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 47, Issue 3, Pages 339–346, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2009.075.

Export Citation

©2009 by Walter de Gruyter Berlin New York.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Beata Znorko, Dariusz Pawlak, Ewa Oksztulska-Kolanek, Tomasz Domaniewski, Anna Pryczynicz, Alicja Roszczenko, Joanna Rogalska, Paweł Lipowicz, Michał Doroszko, Malgorzata Michalina Brzoska, and Krystyna Pawlak
Cytokine, 2018, Volume 106, Page 19
[2]
Xin Xiong, Duraid Hamied Naji, Binbin Wang, Yuanyuan Zhao, Junhan Wang, Dan Wang, Yuting Zhang, Sisi Li, Shanshan Chen, Yufeng Huang, Qin Yang, Xiaojing Wang, Dan Yin, Xin Tu, Qiuyun Chen, Xu Ma, Chengqi Xu, and Qing K. Wang
Journal of Stroke and Cerebrovascular Diseases, 2018
[3]
Neil J. Paloian and Cecilia M. Giachelli
American Journal of Physiology-Renal Physiology, 2014, Volume 307, Number 8, Page F891
[4]
M.M. Nascimento, S.Y. Hayashi, M.C. Riella, and B. Lindholm
Brazilian Journal of Medical and Biological Research, 2014, Volume 47, Number 11, Page 995
[5]
George Koulaouzidis and Michael Henein
Angiology, 2011, Volume 62, Number 7, Page 554
[6]
Helen V Alderson, James P Ritchie, Rachel Middleton, Anders Larsson, Tobias E. Larsson, and Philip A Kalra
Nephrology, 2016, Volume 21, Number 7, Page 566
[7]
Marek Kuźniewski, Danuta Fedak, Paulina Dumnicka, Ewa Stępień, Beata Kuśnierz-Cabala, Marcin Cwynar, and Władysław Sułowicz
Advances in Medical Sciences, 2016, Volume 61, Number 2, Page 269
[8]
Lucie Hénaut, Maria Dolores Sanchez-Nino, Gonzalo Aldamiz-Echevarría Castillo, Ana B Sanz, and Alberto Ortiz
Expert Opinion on Therapeutic Targets, 2016, Volume 20, Number 1, Page 89
[9]
Mona Hussein Elsamahy, Yasmine Ibrahim Elhenawy, and Marwa Magdy Nawar
Journal of Diabetes and its Complications, 2015, Volume 29, Number 4, Page 563
[10]
Susanne Elisabeth Hosbond, Axel Cosmus Pyndt Diederichsen, Lotte Saaby, Lars Melholt Rasmussen, Jess Lambrechtsen, Henrik Munkholm, Niels Peter Rønnow Sand, Oke Gerke, Tina Svenstrup Poulsen, and Hans Mickley
Atherosclerosis, 2014, Volume 236, Number 2, Page 230
[11]
C. Pérez de Ciriza, A. Lawrie, and N. Varo
Clinical Biochemistry, 2014, Volume 47, Number 13-14, Page 1279
[12]
Paul F. Stahls, Daniel J. Lightell, Stephanie C. Moss, Corey K. Goldman, and T. Cooper Woods
Journal of Cardiovascular Translational Research, 2013, Volume 6, Number 2, Page 232
[13]
Georg Fuernau, Sebastian Zaehringer, Ingo Eitel, Suzanne de Waha, Michal Droppa, Steffen Desch, Gerhard Schuler, Volker Adams, and Holger Thiele
International Journal of Cardiology, 2013, Volume 167, Number 5, Page 2134
[14]
Alberto Ortiz, Ziad A. Massy, Danilo Fliser, Bengt Lindholm, Andrzej Wiecek, Alberto Martínez-Castelao, Adrian Covic, David Goldsmith, Gültekin Süleymanlar, Gérard M. London, and Carmine Zoccali
Nature Reviews Nephrology, 2011, Volume 8, Number 3, Page 141
[15]
M. Mesquita, A. Demulder, F. Wolff, C. Mélot, N. Damry, M. Dratwa, and P. Bergmann
Transplantation Proceedings, 2010, Volume 42, Number 9, Page 3444
[16]
J.-J. Body, P. Bergmann, S. Boonen, J.-P. Devogelaer, E. Gielen, S. Goemaere, J.-M. Kaufman, S. Rozenberg, and J.-Y. Reginster
Osteoporosis International, 2012, Volume 23, Number S1, Page 1
[17]
A. Quercioli, F. Mach, M. Bertolotto, S. Lenglet, N. Vuilleumier, K. Galan, S. Pagano, V. Braunersreuther, G. Pelli, V. Pistoia, G. Bianchi, G. Cittadini, G. L. Viviani, A. Pende, P. Roux-Lombard, A. Thomas, C. Staub, O. Ratib, F. Dallegri, T. H. Schindler, and F. Montecucco
Thrombosis and Haemostasis, 2011, Volume 107, Number 1, Page 124
[18]
Ewa Stępień, Ewa Wypasek, Katarzyna Stopyra, Małgorzata Konieczyńska, Małgorzata Przybyło, and Mieczysław Pasowicz
Clinical Biochemistry, 2011, Volume 44, Number 10-11, Page 826
[19]
JIAN-QING JIANG, SHAN LIN, PENG-CHENG XU, ZHEN-FENG ZHENG, and JUN-YA JIA
Nephrology, 2011, Volume 16, Number 6, Page 588
[20]
Shreenidhi M. Venuraju, Ajay Yerramasu, Roger Corder, and Avijit Lahiri
Journal of the American College of Cardiology, 2010, Volume 55, Number 19, Page 2049
[21]
A. Nakashima, J. J. Carrero, A. R. Qureshi, T. Hirai, N. Takasugi, T. Ueno, Y. Taniguchi, B. Lindholm, and N. Yorioka
Osteoporosis International, 2011, Volume 22, Number 6, Page 1695
[22]
Alessandra Quercioli, Giorgio Luciano Viviani, Franco Dallegri, François Mach, and Fabrizio Montecucco
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2010, Volume 9, Number 4, Page 227
[23]
Alessandra Quercioli, Fabrizio Montecucco, Maria Bertolotto, Luciano Ottonello, Aldo Pende, François Mach, and Franco Dallegri
European Journal of Clinical Investigation, 2010, Volume 40, Number 7, Page 645

Comments (0)

Please log in or register to comment.
Log in